Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort
- PMID: 17099314
- DOI: 10.1097/01.qai.0000243120.67529.78
Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort
Abstract
Background: Previous studies described infective endocarditis (IE) in the era before highly active antiretroviral therapy (HAART); however, IE has not been well studied in the current HAART era. We evaluated the incidence of, risk factors for, clinical presentation, and 1-year outcomes of IE in HIV-infected patients.
Methods: We evaluated all cases of IE diagnosed between 1990 and 2002 in patients followed at the Johns Hopkins Hospital outpatient HIV clinic. To identify factors associated with IE in the current era of HAART, a nested case-control analysis was employed for all initial episodes of IE occurring between 1996 and 2002. Logistic regression analyses were used to assess risk factors for IE and factors associated with 1-year mortality.
Results: IE incidence decreased from 20.5 to 6.6 per 1000 person-years (PY) between 1990 and 1995 and 1996 and 2002. The majority of IE cases were male (66%), African American (90%), and injection drug users (IDUs) (85%). In multivariate regression, an increased risk of IE occurred in IDUs (AOR, 8.71), those with CD4 counts <50 cells/mm, and those with HIV-1 RNA >100,000 copies/mL (AOR, 3.88). Common presenting symptoms included fever (62%), chills (31%), and shortness of breath (26%). The most common etiologic organism was Staphylococcus aureus (69%; of these 11 [28%] were methicillin resistant). Within 1 year, 16% had IE recurrence, and 52% died. Age over 40 years was associated with increased mortality.
Conclusions: IE rates have decreased in the current HAART era. IDUs and those with advanced immunosuppression are more likely to develop IE. In addition, there is significant morbidity and 1-year mortality in HIV-infected patients with IE, indicating the need for more aggressive follow-up, especially in those over 40 years of age. Future studies investigating the utility of IE prophylaxis in HIV patients with a history of IE may be warranted.
Similar articles
-
Infective endocarditis in intravenous drug abusers and HIV-1 infected patients.Infect Dis Clin North Am. 2002 Jun;16(2):273-95, vii-viii. doi: 10.1016/s0891-5520(01)00008-3. Infect Dis Clin North Am. 2002. PMID: 12092473 Review.
-
Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients.Cardiol Clin. 2003 May;21(2):167-84, v-vi. doi: 10.1016/s0733-8651(03)00025-0. Cardiol Clin. 2003. PMID: 12874891 Review.
-
Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users.Arch Intern Med. 1998 Oct 12;158(18):2043-50. doi: 10.1001/archinte.158.18.2043. Arch Intern Med. 1998. PMID: 9778205
-
Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients.Infection. 2007 Jun;35(3):154-60. doi: 10.1007/s15010-007-5125-0. Infection. 2007. PMID: 17565456
-
Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature.Clin Microbiol Infect. 2003 Jan;9(1):45-54. doi: 10.1046/j.1469-0691.2003.00505.x. Clin Microbiol Infect. 2003. PMID: 12691542 Review.
Cited by
-
Cotton Fever: Does the Patient Know Best?J Gen Intern Med. 2016 Apr;31(4):442-4. doi: 10.1007/s11606-015-3424-1. J Gen Intern Med. 2016. PMID: 26105678 Free PMC article.
-
Infective endocarditis.Nat Rev Cardiol. 2011 Jun;8(6):322-36. doi: 10.1038/nrcardio.2011.43. Epub 2011 Apr 12. Nat Rev Cardiol. 2011. PMID: 21487430 Review.
-
Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.BMC Infect Dis. 2011 Oct 31;11:298. doi: 10.1186/1471-2334-11-298. BMC Infect Dis. 2011. PMID: 22040268 Free PMC article.
-
Right-Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment.J Am Heart Assoc. 2020 Aug 4;9(15):e017293. doi: 10.1161/JAHA.120.017293. Epub 2020 Jul 23. J Am Heart Assoc. 2020. PMID: 32700630 Free PMC article. Review.
-
The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1227-45. doi: 10.1007/s10096-016-2660-6. Epub 2016 May 11. Eur J Clin Microbiol Infect Dis. 2016. PMID: 27170145
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials